User:Mandy Bechman/Sandbox 1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 18: Line 18:




== Disease ==
==Importance==
 
===Tirzepatide===
===Tirzepatide===
One of the most promising treatments to GIP malfunction is <scene name='10/1038867/Tirzepatide/2'>Tirzepatide</scene>, also known as Mounharo, created by Eli Lily. It is an antidiabetic as well as weight loss drug. The structure of Tirzepatide functions as an incretin receptor agonist to GIP by activating GIP's receptor and producing insulin.  
One of the most promising treatments to GIP malfunction is <scene name='10/1038867/Tirzepatide/2'>Tirzepatide</scene>, also known as Mounharo, created by Eli Lily. It is an antidiabetic as well as weight loss drug. The structure of Tirzepatide functions as an incretin receptor agonist to GIP by activating GIP's receptor and producing insulin.  

Revision as of 14:40, 18 April 2024

H. sapiens Glucose-dependent Insulinotropic Polypeptide

GIP Structure

Drag the structure with the mouse to rotate

References

[1]. [2].

  1. ↑ Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Investig. 2010 Apr 22;1(1-2):8-23. PMID:24843404 doi:10.1111/j.2040-1124.2010.00022.x
  2. ↑ Mayendraraj A, Rosenkilde MM, Gasbjerg LS. GLP-1 and GIP receptor signaling in beta cells interactions and co-stimulation. Peptides. 2022 May;151:170749. PMID:35065096 doi:10.1016/j.peptides.2022.170749

Proteopedia Page Contributors and Editors (what is this?)

Mandy Bechman